Navigation Links
Hydroxycut(R) Litigation Focus of July 28 Conference in San Francisco
Date:6/12/2009

SAN FRANCISCO, June 12 /PRNewswire/ -- The Hydroxycut(R) controversy - according to noted plaintiff attorney Vance Andrus - has all the characteristics of the "next big one" - the next massive products litigation for plaintiff attorneys. But Iovate Health Sciences Inc., maker of the myriad Hydroxycut weight-loss and muscle-building products, says the FDA's accounting of adverse event reports is "small relative to the many millions of people who have used Hydroxycut products."

HB Litigation Conferences, formerly Mealey's Conferences, is holding a half-day seminar - titled Hydroxycut(R) Litigation Conference - at the Mission Bay Conference Center at the University of California in San Francisco on Tuesday, July 28, 2009.

Designed to educate plaintiff and defense attorneys, companies and insurers, the program is being chaired by Vance Andrus of Andrus Boudreaux PLC in New Orleans and leading California trial attorney Thomas Girardi of Girardi & Keese in Los Angeles.

Annesley DeGaris of Cory Watson Crowder & Degaris P.C. of Birmingham, Ala., will detail the products and ingredients. DeGaris noted on a recent HB teleconference that there were 14 Hydroxycut(R) product lines for weight loss supplements and within those lines, there were 56 variations based on quantity, size and flavor.

Anne Andrews of Andrews & Thornton in Irvine, Calif., will provide an overview of the $23.7 billion dietary supplement industry, including the history of Hydroxycut(R) maker Iovate / Muscletech.

A "Panel Defendants' Forum" will address lessons from Ephedra, distributors, ingredient makers, jurisdiction and consolidation. Moderated by Thomas Clark of Andrus Boudreaux, panelists are John Boundas of Williams Kherkher Hart Boundas in Houston; Annesley DeGaris of Cory, Watson; and Neil Overholtz of Aylstock, Witkin, Kreis & Overholtz in Pensacola, Fla.

Tho
'/>"/>

SOURCE HB Litigation Conferences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Fenwal Statement Regarding Patent Litigation
2. Niutang Sucralose Patent Litigation Successfully Concluded
3. LawInfo Provides Access to Qualified Hydroxycut Litigation Attorneys Nationwide
4. Court Rules in Favor of HealthSouth in Litigation Involving General Medicine, P.C.
5. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
6. Jonathan Perkins Injury Lawyers Adds Two Experienced Litigation Attorneys to Connecticut Team
7. Benzene Litigation Conference July 24
8. Chinese Drywall Litigation Subject of Conference and Two Teleconferences
9. Blue Cross Reverses Position on Autism After Federal Court Litigation Intensifies
10. HB Litigation Conferences Announces Conference and Two Teleconferences on Chinese Drywall Litigation and Insurance
11. Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Miriam Hospital have found that people with mobility ... of smoking than those without mobility impairments. Additionally, ... attempt quitting than those without mobility impairments, and ... this population. The study and its findings are ... American Journal of Public Health . ...
(Date:7/11/2014)... has found that organic foods and crops have ... including more antioxidants and fewer, less frequent pesticide ... 343 peer-reviewed publications comparing the nutritional quality and ... fruits, vegetables, and grains. The study team applied ... and non-organic foods. , "Science marches on," ...
(Date:7/11/2014)... Delaying surgery to repair damage to the anterior cruciate ligament ... knee -- could increase a young athlete,s risk for further ... 130 patients, aged 8 to 16, who had ACL reconstruction ... weeks after their injury, 37 had surgery six to 12 ... months after their injury. The youngsters who had surgery ...
(Date:7/11/2014)... Prostate cancer patients are more likely to be diagnosed ... sooner if they also have depression, a new study ... American men who were diagnosed with localized prostate cancer ... Nearly 1,900 of the patients had been diagnosed with ... was discovered. "Men with intermediate- or high-risk prostate ...
(Date:7/11/2014)... Ticket Down is a reliable ... Train Amphitheatre in Wheatland, CA. In the Sacramento ... what the Sleep Train Amphitheatre can do for music fans. ... over the course of its existence and can seat 18,500 ... in Wheatland (Sacramento metro area) will host the “That’s My ...
Breaking Medicine News(10 mins):Health News:Miriam Hospital study examines smoking prevalence 2Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 3
... of refugees settled in the makeshift relief camps of ... of Chhattisgarh.// ,UNICEF will specifically look into ... settled in these camps. ,According to ... the organisation's representative in India, met Chhattisgarh chief minister ...
... towards water to chill out. Places such as backyard pool, hot ... very for cautious and always follow the instructions of their parents. ... all the safety measures such as installing the pool fences and ... fail to install the child proof safety measures as it is ...
... gay men who have also been diagnosed as HIV-positive seemed ... status to others//. ,The study, the first of ... HIV-positive men who are often uncertain whether to tell friends, ... that causes AIDS. It was published in the April issue ...
... fees for admittance into various medical courses offered by ... education and research department// of the Punjab government. The ... medical and paramedical courses. ,Representatives of medical ... consultation regarding the actual fees to be fixed for ...
... in which the sinuses become inflamed or infected affecting ... conventional surgery//. But now Acclarent has come up with ... a small balloon in the sinus cavity which clears ... breakthrough that offers hope to many sinusitis sufferers. It ...
... High Court has sought an explanation from medical superintendent ... disclosure of sufficient details after a boy, suffering from ... the hospital in 2001. ,Aggrieved with the ... the hospital to explain its unwillingness to disclose details ...
Cached Medicine News:Health News:Hot Tubs and Spas in the News for Safety Measures 2Health News:Gays Have No Regrets 2Health News:Gays Have No Regrets 3Health News:Provisional Fees For Medical Courses Fixed By Punjab Government 2Health News:Teething Problems of Sinuplasty 2
(Date:7/11/2014)... 11, 2014 Patient engagement has become ... organizations are turning to an assortment of marketing ... part of this evolving approach to patient engagement, ... and engage patients throughout their experiences with a ... By mapping the patient journey and employing a ...
(Date:7/11/2014)... 11, 2014  Rock Creek Pharmaceuticals, Inc. (NASDAQ: ... that the Food and Drug Administration ("FDA"), has notified ... RCP,s Investigational New Drug ("IND") application before granting the ... US. Dr. Chris Chapman , RCP,s ... on our IND. When we receive the agency,s official ...
(Date:7/11/2014)... DALLAS , July 11, 2014 ... report "Scintillator Market by Composition of Material, Application ... and others), End Product (Personal Instrument, Hand-Held Instruments, ... Forecast and Analysis to 2013 - 2020", published by MarketsandMarkets, ... a CAGR of 5.62% from 2014 to 2020, ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4
... , , , ... (Nasdaq: AMGN ) today announced the publication of results from ... at reducing fracture risk in more than 7,800 women with postmenopausal osteoporosis ... deprivation therapy (ADT) leading to bone loss. In both studies, published today ...
... , , , ... BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the ... chronically infected with the hepatitis C virus (HCV). The trial, run in ... clemizole monotherapy in the absence of interferon. , , ...
Cached Medicine Technology:Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 2Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 3Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 5Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 6Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 7Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 8Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 9Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 10Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 11Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 2Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 3
Standard general retractor system. Fully-adjustable to maintain a low profile in any approach and any patient. Blades can be stacked on top of each other in the operative site....
These retractors are packaged singly ready for sterilization at your facility....
... Pipetman Concept is a revolutionary ... and flexibility in mind, Pipetman Concept ... direct pipette-to-PC connectionthe only one of ... used with Diamond Tips from Gilson, ...
... 3 - Vivid family system designed to ... cardiovascular performance, and offer an even wider ... and the OR. , ,From color flow ... connectivity, the new Vivid 3 offers a ...
Medicine Products: